August 2nd 2021
Gareth J. Morgan, MD, PhD, discusses differences in low- and high-risk multiple myeloma.
May 27th 2021
Gareth J. Morgan, MD, PhD, discusses optimizing treatments for patients with ultra high–risk multiple myeloma.
June 11th 2020
Gareth J. Morgan, MD, PhD, discusses the evolution of treatment options in multiple myeloma.
May 22nd 2020
Gareth J. Morgan, MD, PhD, provides insight on determining treatment selection for patients with multiple myeloma.
May 21st 2020
April 17th 2020
Gareth J. Morgan, MD, PhD, discusses research examining idecabtagene vicleucel in relapsed/refractory multiple myeloma.
April 14th 2020
Gareth J. Morgan, MD, PhD, discusses the role of venetoclax in treating patients with multiple myeloma.
March 18th 2020
Gareth J. Morgan, MD, PhD, a professor in the Department of Medicine and director of Multiple Myeloma Research, NYU Langone Health’s Perlmutter Cancer Center, discusses BCMA-targeted antibody-drug conjugates (ADCs) in multiple myeloma.